Business Insider
My Markets Watchlist
Markets
News
Search
Business
Strategy
Economy
Finance
Retail
Advertising
Careers
Media
Real Estate
Small Business
The Better Work Project
Tech
Science
AI
Enterprise
Transportation
Startups
Innovation
Markets
Stocks
Indices
Commodities
Crypto
Currencies
ETFs
Lifestyle
Entertainment
Culture
Travel
Food
Health
Parenting
Reviews
Tech
Streaming
Tickets
Home
Kitchen
Style
Beauty
Gifts
Deals
Politics
Military & Defense
Law
Education
Personal Finance
Banking
Savings
Best Savings Accounts
Raisin Review
Checking Accounts
Best Checking Accounts
Chime Checking Account
SoFi Checking and Saving
Best Money Market Accounts
CDs
Best CD Rates
Best Bank Account Bonuses
Cash Back Debit Cards
Best Banks
CIT Bank Review
UFB Direct Bank
Small Business Banking
Credit Cards
Credit Scores
Credit Monitoring
Best Credit Cards
Best Cash Back Credit Cards
Best Rewards Credit Cards
Best Travel Credit Cards
Best 0% APR Credit Cards
Best Balance Transfer Credit Cards
Best First Credit Cards
Best Business Credit Cards
Discover it Cash Back Credit Card
Chase Sapphire Preferred Credit Card
Investing
Financial Planning
Retirement
Taxes
Loans
Best personal loans
Best debt consolidation loans
Best Loans for Bad Credit
Student Loans
Best Student Loans
Best Student Loan Refinance
Mortgages
Best mortgage lenders
Best mortgage refinance lenders
Best FHA Lenders
Best HELOC Lenders
Insurance
Best Car Insurance
Homeowners Insurance
Best Homeowners Insurance
Best Renters Insurance
Life Insurance
Best Life Insurance
Pet Insurance
Best Pet Insurance
Travel Insurance
Best Travel Insurance
SquareMouth Travel Insurance
Identity Theft Protection
Video
Big Business
Food Wars
So Expensive
Still Standing
Boot Camp
News for BeiGene Ltd (spons. ADRs)
Markets Insider Automation
681d
BeiGene earnings preview: what Wall Street is expecting
Benzinga
687d
Growing Competition in Hematology, Aesthetics Complicates AbbVie's Post-Humira Landscape, Analyst Says
Seeking Alpha
692d
BeiGene drug gets positive EMA panel opinion for esophageal cancer
TipRanks
694d
Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV) and BeiGene (BGNE)
Benzinga
695d
BeiGene's Brukinsa Positioned as Preferred BTK Inhibitor: Analyst Says Survey Supports Bullish View
Benzinga
695d
Benzinga's Top Ratings Upgrades, Downgrades For July 17, 2023
TipRanks
696d
Citi Reaffirms Their Buy Rating on BeiGene (BGNE)
Seeking Alpha
698d
Catalyst Watch: Microsoft-Activision Blizzard drama, Splunk event and Nasdaq 100 rebalancing countdown
Seeking Alpha
701d
BeiGene wins FDA review to expand Brukinsa label for lymphoma
TipRanks
701d
BeiGene (BGNE) Receives a Hold from Bank of America Securities
Seeking Alpha
702d
Novartis ends licensing deal with BeiGene
PR Newswire
712d
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages BeiGene, Ltd. Investors to Inquire About Securities Class Action Investigation - BGNE
Benzinga
712d
Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2023
Benzinga
712d
Why This BeiGene Analyst Slashes Forecast By Almost 42%
Benzinga
713d
NVIDIA To Rally Over 16%? Here Are 10 Other Analyst Forecasts For Friday
TipRanks
713d
Bernstein Sticks to Its Hold Rating for BeiGene (BGNE)
TipRanks
715d
Analysts Offer Insights on Healthcare Companies: Amedisys (AMED), Structure Therapeutics, Inc. Sponsored ADR (GPCR) and BeiGene (BGNE)
PR Newswire
719d
BGNE LOSS ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages BeiGene, Ltd. Investors to Inquire About Securities Class Action Investigation - BGNE
Benzinga
728d
Why MicroVision Shares Are Trading Higher By 28%; Here Are 20 Stocks Moving Premarket
Benzinga
728d
Gambling.com, Editas Medicine And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Seeking Alpha
728d
BTBT, GREE and CIFR among pre-market losers
Seeking Alpha
728d
AbbVie files patent lawsuit over BeiGene’s cancer drug - Bloomberg
Seeking Alpha
728d
Biggest stock movers today: MicroVision, BeiGene and more
TipRanks
729d
Analysts Offer Insights on Healthcare Companies: Vir Biotechnology (VIR) and BeiGene (BGNE)
TipRanks
757d
Bank of America Securities Reaffirms Their Hold Rating on BeiGene (BGNE)
TipRanks
765d
SVB Securities Remains a Buy on BeiGene (BGNE)
TipRanks
769d
Bernstein Sticks to Its Buy Rating for BeiGene (BGNE)
Seeking Alpha
770d
BeiGene Non-GAAP EPS of -$3.34 beats by $0.32, revenue of $447.8M misses by $1.64M
Seeking Alpha
771d
Immix stock slumps ~20% amid interim data for IMX-110 in colorectal cancer
Seeking Alpha
778d
Zymeworks, Jazz in pact over cancer antibody zanidatamab
Seeking Alpha
784d
Novartis, BeiGene tislelizumab meets main goal in gastric/esophagus cancer trial
InvestorPlace
784d
7 Biotech Stocks That Could Cure Your Portfolio Woes
TipRanks
792d
Analysts Offer Insights on Healthcare Companies: BeiGene (BGNE), Zynex (ZYXI) and Legend Biotech (LEGN)
Seeking Alpha
794d
Premier cancer research event, AACR is starting this week; Here is what to expect
TipRanks
809d
J.P. Morgan Analysts Say These 2 Stocks Are Their Top Picks for 2023
TipRanks
811d
5 Best Healthcare Stocks to Invest in Now, According to Analysts
Seeking Alpha
814d
Zymeworks a buy at Wells Fargo on royalty streams, future milestones
TipRanks
834d
Analysts Offer Insights on Healthcare Companies: BeiGene (BGNE), Arcus Biosciences (RCUS) and Karuna Therapeutics (KRTX)
TipRanks
834d
SVB Securities Sticks to Their Buy Rating for BeiGene (BGNE)
TipRanks
834d
Guggenheim Keeps Their Buy Rating on BeiGene (BGNE)
TipRanks
835d
Analysts Conflicted on These Healthcare Names: ACADIA Pharmaceuticals (ACAD), Henry Schein (HSIC) and BeiGene (BGNE)
Benzinga
836d
Nasdaq, S&P 500 Futures Rebound In New Trading Week But Rising Bond Yields Remain A Risk
Seeking Alpha
836d
BeiGene GAAP EPADS of -$4.29 misses by $0.10, revenue of $380.1M misses by $8.07M
Seeking Alpha
838d
BeiGene Q4 2022 Earnings Preview
Seeking Alpha
857d
Quebec to fund BeiGene's Brukinsa to treat rare blood cancer
Seeking Alpha
861d
Roche CEO drags Arcus, iTeos lower after comments on cancer trial
TipRanks
869d
Morgan Stanley Reaffirms Their Buy Rating on BeiGene (BGNE)
Benzinga
873d
4 Analysts Have This to Say About BeiGene
Benzinga
874d
Draganfly To Rally Around 87%? Here Are 10 Other Analyst Forecasts For Friday
TipRanks
874d
Analysts Are Bullish on These Healthcare Stocks: Johnson & Johnson (JNJ), BeiGene (BGNE)
Page
Page
Page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
Page
Page
Find News
News
GO
Otomatik - 146.75.116.64
CloudFlare DNS
Türk Telekom DNS
Google DNS
Open DNS
OSZAR »